PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.\', \'Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts.\', \'Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.\', \'Department of Pharmacy, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.\', \'Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.\', \'Division of Endocrinology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.\', \'Department of Nephrology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.34067/KID.0006452020
?:doi
?:hasPublicationType
?:journal
  • Kidney360
is ?:pmid of
?:pmid
?:pmid
  • 35368823
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Niacinamide May Be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all